DGX · XBRL financial data

Quest Diagnostics financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (DGX's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Revenue from contracts with customers	2,288*	2,366	2,397	2,488	2,621*	2,652	2,761	2,816	2,806*	2,895	3,043	3,097
Cost of revenue	1,552*	1,595	1,593	1,677	1,763*	1,789	1,818	1,867	1,896*	1,953	2,016	2,055
Selling, general and administrative	407*	440	416	448	466*	476	486	501	504*	504	529	523
Other operating income (expense)	(35)*	(2)	(4)	(1)	6*	(2)	20	(23)	17*	(2)	(1)	(3)
Operating income (loss)	267*	300	355	330	361*	346	438	386	386*	399	459	479
Interest expense	46*	49	47	—	—	—	—	—	—	—	—	—
Other income (expense)	10*	9	3	15	3*	(3)	13	8	8*	(2)	16	(2)
Income tax expense (benefit)	40*	66	74	65	68*	59	97	77	81*	74	88	99
Net income (loss)	192*	194	229	226	222*	220	282	245	245*	252	320	312
Earnings per share, basic USD per share	1.71*	1.74	2.05	2.01	2.02*	1.97	2.51	2.18	2.25*	2.27	2.88	2.82
Earnings per share, diluted USD per share	1.73*	1.72	2.03	1.99	1.93*	1.94	2.47	2.16	2.17*	2.24	2.84	2.78
Weighted average shares, basic millions of shares	112*	111	111	112	110*	111	112	112	109*	110	111	110
Weighted average shares, diluted millions of shares	111*	112	112	113	115*	113	113	113	113*	112	112	112

Balance sheet

CSV

Fiscal quarters (DGX's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Cash and cash equivalents	686	474	271	764	549	188	319	432	420	393	626	797
Accounts receivable	1,210	1,322	1,319	1,376	1,304	1,404	1,419	1,456	1,408	1,587	1,666	1,712
Inventory	190	181	182	184	188	189	187	186	189	225	233	218
Prepaid and other current assets	286	251	245	299	351	294	273	333	361	361	319	390
Total current assets	2,372	2,228	2,017	2,623	2,392	2,075	2,198	2,407	2,378	2,566	2,844	3,117
Property and equipment, net	1,816	1,810	1,832	2,093	2,113	2,098	2,120	2,145	2,203	2,189	2,219	2,275
Right-of-use asset	602	579	603	661	651	656	655	649	657	691	678	670
Goodwill	7,733	7,830	7,885	8,605	8,856	8,849	8,883	8,901	8,945	9,120	9,112	9,112
Total assets	14,022	13,954	13,881	16,095	16,153	15,797	15,969	16,197	16,225	16,673	16,939	17,221
Accrued liabilities	287	—	—	—	306	—	—	—	338	—	—	—
Current portion of long-term debt	303	906	606	603	602	1	504	504	504	503	10	10
Total current liabilities	1,815	2,298	2,012	2,092	2,169	1,441	2,024	2,134	2,278	2,177	1,788	1,834
Long-term debt	4,410	—	—	5,648	5,615	—	—	—	5,167	—	5,632	5,540
Lease liability, non-current	503	489	507	543	535	538	540	534	537	574	561	554
Retained earnings	8,825	8,935	9,080	9,222	9,360	9,490	9,682	9,837	9,994	10,151	10,374	10,593
Total stockholders' equity	6,307	6,432	6,617	6,809	6,778	6,929	7,228	7,258	7,170	7,366	7,516	7,632
Total liabilities and equity	14,022	13,954	13,881	16,095	16,153	15,797	15,969	16,197	16,225	16,673	16,939	17,221
Common shares outstanding (cover page) millions of shares	111	111	111	112	111	112	112	111	110	111	110	110

Cash flows

CSV

Fiscal quarters (DGX's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Net income (loss)	192*	194	229	226	222*	220	282	245	245*	252	320	312
Stock-based compensation	19*	22	20*	19*	27*	22	21*	20*	25*	20	23*	20*
Depreciation and amortization	109*	116	117	125	135*	140	143	142	145*	147	146	147
Net cash from operating activities	527*	154	360*	356*	464*	314	544*	563*	465*	278	597*	611*
Purchases of property and equipment	72*	104	92*	106*	123*	117	108*	144*	158*	114	138*	166*
Net cash from investing activities	(114)*	(213)	(200)*	(1,633)*	(502)*	(115)	(124)*	(201)*	(191)*	(152)	(134)*	(169)*
Share repurchases	275*	—	—	—	151*	—	—	150*	300*	—	—	150*
Dividends paid	80*	79	84*	84*	84*	84	90*	89*	90*	88	96*	95*
Net cash from financing activities	130*	(153)	(363)*	1,770*	(170)*	(561)	(293)*	(247)*	(287)*	(152)	(229)*	(271)*
Net change in cash	543*	(212)	(203)*	493*	(215)*	(361)	131*	113*	(12)*	(27)	233*	171*

Compare with peers

SIC 8071 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8071 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Quest Diagnostics	797	3,097	611*	110.0M	—	Q3 FY26 10-QSep 30, 2026
Labcorp Holdings	262	3,810	564*	81.2M	—	Q3 FY26 10-QSep 30, 2026
Natera	1,092	753	55*	144.1M	—	Q2 FY26 10-QJun 30, 2026
Exact Sciences	956	878*	152*	190.9M	—	Q4 FY25 10-KDec 31, 2025
Guardant Health	1,053	335	(58)*	134.2M	18.2 quarters	Q2 FY26 10-QJun 30, 2026
RadNet	726	623	94*	78.7M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.